60 Degrees Pharmaceuticals (SXTP) Net Margin (QoQ) (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) Net Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 2.95 Mn | 1.92 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96,663.00 |
| Dec 31, 2025 | 20,663.00 |
| Sep 30, 2025 | 118,942.00 |
| Jun 30, 2025 | -49,324.00 |
| Mar 31, 2025 | -32,359.00 |
| Dec 31, 2024 | 77,720.00 |
| Sep 30, 2024 | 175,148.00 |
| Jun 30, 2024 | -372,289.00 |
| Mar 31, 2024 | 105,630.00 |
| Dec 31, 2023 | -875,629.00 |
| Sep 30, 2023 | 882,692.00 |
| Jun 30, 2023 | 1.43 Mn |
| Sep 30, 2022 | -43,808.00 |